3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with verapamil in 2 studies
Studies (3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin) | Trials (3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin) | Recent Studies (post-2010) (3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
---|---|---|---|---|---|
38 | 0 | 0 | 17,621 | 1,527 | 2,067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gordon, GR; Johl, JS; Peters, JH; Streeter, DG | 1 |
Acton, EM; Peters, JH; Streeter, DG; Taylor, DL | 1 |
2 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and verapamil
Article | Year |
---|---|
Uptake and retention of morpholinyl anthracyclines by adriamycin-sensitive and -resistant P388 cells.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Doxorubicin; Drug Resistance; Leukemia P388; Leukemia, Experimental; Mice; Naphthacenes; Structure-Activity Relationship; Verapamil | 1986 |
Comparative cytotoxicities of various morpholinyl anthracyclines.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Doxorubicin; Drug Resistance; Drug Synergism; Leukemia P388; Leukemia, Experimental; Mice; Time Factors; Verapamil | 1985 |